Ironwood Pharmaceuticals (IRWD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IRWD Ironwood Pharmaceuticals

Watchlist

4.195
-1.815-30.20%

Trading Aug 8 13:19 ET

666.83MMarket Cap52.44P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Ironwood Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Financial Results and Revised Its FY24 Guidance
BenzingaAug 8 11:04 ET
Ironwood Pharmaceuticals Non-GAAP EPS of $0.00 Misses by $0.14, Revenue of $94.4M Misses by $12.6M
Seeking AlphaAug 8 07:12 ET
Express News | Ironwood Pharmaceuticals Inc: Sees 2024 Total Revenue $350 Mln - $375 Mln
ReutersAug 8 07:11 ET
Earnings Flash (IRWD) IRONWOOD PHARMACEUTICALS Reports Q2 Revenue $94.4M
MT NewswiresAug 8 07:08 ET
Earnings Flash (IRWD) IRONWOOD PHARMACEUTICALS Posts Q2 EPS $0.00
MT NewswiresAug 8 07:08 ET
Express News | Ironwood Pharmaceuticals Q2 Adjusted Net Income USD 1.508 Million Vs. IBES Estimate USD 23.5 Million
ReutersAug 8 07:00 ET

Comments

Meltyy

May 12 21:23

🎯 Ph 3 readouts in Q2 2024...

$United Therapeutics (UTHR.US)$ Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3...

Luzi Ann Santos

Feb 29 10:54

Columns Ironwood Pharma Shares Tank 40% as Drug Trial Misses Secondary Goal

$Ironwood Pharmaceuticals (IRWD.US)$ shares sank almost 40% after the drugmaker said its global phase III trial of Apraglutide, a treatment for short bowel syndrome, missed two of its four secondary goals.
That muddies the prospects for the company that's seeking to expand its product pipeline beyond Linzess.
Ironwood, which has been operating at a loss, sourced almost ll of its $117.6 million revenue in 2023 from its collaborati...

Meltyy

Feb 21 22:05

Biotech Stock Catalyst Watchlist

🎯 Ph 3 readouts in Q1 2024...
$Pfizer (PFE.US)$ Phase 3
$Palatin Technologies (PTN.US)$ Phase 3
$Annovis Bio (ANVS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3
$Atea Pharmaceuticals (AVIR.US)$ Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 3
$Axsome Therapeutics (AXSM.US)$ Phase 3
$ $Novocure (NVCR.US)$ Phase 3
$ROCHE HOLDING AG (RHHBY.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$ACADIA Pharmaceuticals (ACAD.US)$ Phase 3
$Sellas Life Sciences (SLS.US)$...

Moomoo AI

Feb 18 08:16

Thomas McCourt's recent sale at the current share price of US$14.58 raises caution. More selling than buying by insiders over the past year and low insider ownership could concern potential investors.